All I've seen over there is clinically insignificant data and a guy hounded for pointing it out. Not to mention dozens of posters furious with management for a lack of communication, deprioritised assets, a sitting chair throwing retail under the bus, and a company generally just bleeding shareholders dry in an attempt to either acquire a worthy asset, or more likely, just funding their monthly chandelier cleaning bill.
You're deflecting.
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant, page-59
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.56 |
Change
0.010(0.65%) |
Mkt cap ! $265.8M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.56 | $1.51 | $95.69K | 62.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3015 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 4018 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |